Charlotte Rawcliffe

Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

John P. Neoptolemos, Deborah Stocken, Claudio Bassi et al. · JAMA · 2010 · 1.4K citations

Medicine, Oncology, Pharmacotherapy +17

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma

John P. Neoptolemos, Malcolm J. Moore, Trevor F. Cox et al. · JAMA · 2012 · 592 citations

Medicine, Oncology, Surgery +17

Optimal Duration and Timing of Adjuvant Chemotherapy After Definitive Surgery for Ductal Adenocarcinoma of the Pancreas: Ongoing Lessons From the ESPAC-3 Study

Juan W. Valle, Daniel H. Palmer, Richard Jackson et al. · Journal of Clinical Oncology · 2014 · 455 citations · Full text

Medicine, Oncology, Surgery +16

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Gary Middleton, Paul Silcocks, Trevor F. Cox et al. · The Lancet Oncology · 2014 · 374 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

William Greenhalf, Paula Ghaneh, John P. Neoptolemos et al. · JNCI Journal of the National Cancer Institute · 2013 · 333 citations

Medicine, Cancer Biology, Oncology +16